HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nguyen, B. D. Search for Related Content PubMed PubMed Citation Articles by Nguyen, B. D. Related Collections Nuclear Medicine Related Article

Parathyroid Imaging with Tc-99m Sestamibi Planar and SPECT Scintigraphy¹

¹ From the Department of Radiology, Mayo Clinic Scottsdale, 13400 E Shea Blvd, Scottsdale, AZ 85259. Presented as a scientific exhibit at the 1997 RSNA scientific assembly. Received June 17, 1998; revision requested July 13 and received September 11; accepted September 14. Address reprint requests to the author.

Technetium-99m sestamibi planar and single-photon-emission computed tomographic scintigraphy is useful in the diagnosis of parathyroid gland disease. To understand the various patterns of parathyroid disease, it is important to understand parathyroid embryology and anatomy. The spectrum of parathyroid disease demonstrated with Tc-99m sestamibi scintigraphy includes eutopic disease, ectopic disease, solitary adenoma, double or multiple adenomas, cystic adenoma, lipoadenoma, multiple endocrine neoplasia, hyperfunctioning parathyroid transplant, entities with atypical washout, and nonparathyroid entities that take up Tc-99m sestamibi. The diagnosis of parathyroid tumors with Tc-99m sestamibi scintigraphy is based on the difference in clearance rates between the thyroid and diseased parathyroid glands, and any condition that interferes with radiotracer clearance will limit the effectiveness of the study. The technique is most clearly indicated for the preoperative evaluation of recurrent or persistent hyperparathyroidism, but it is increasingly being used before the initial surgical exploration as well. Subtraction Tc-99m sestamibi and iodine-123 scintigraphy may be helpful in difficult cases. Parathyroid hyperplasia, multisite parathyroid disease, and concomitant thyroid and parathyroid disease remain potential hurdles for this scintigraphic technique, and optimal handling of these problems still relies heavily on the skill and experience of the endocrine surgeon.

Index Terms: Parathyroid, hyperparathyroidism, 274.531 • Parathyroid, neoplasms, 274.363 • Parathyroid, radionuclide studies, 274.12175

Related Article

Invited Commentary

Eduard V. Kotlyarov
RadioGraphics 1999 19: 615-616. [Full Text] [PDF]

This article has been cited by other articles:

				Pathology Quiz Case 2: Diagnosis Arch Otolaryngol Head Neck Surg, December 1, 2006; 132(12): 1392 - 1393. [Full Text] [PDF]

				A. F. Scarsbrook, R. V. Thakker, J. A. H. Wass, F. V. Gleeson, and R. R. Phillips Multiple Endocrine Neoplasia: Spectrum of Radiologic Appearances and Discussion of a Multitechnique Imaging Approach. RadioGraphics, March 1, 2006; 26(2): 433 - 451. [Abstract] [Full Text] [PDF]

				M.-Y. Jeung, B. Gasser, A. Gangi, A. Bogorin, D. Charneau, J. M. Wihlm, J.-L. Dietemann, and C. Roy Imaging of Cystic Masses of the Mediastinum RadioGraphics, October 1, 2002; 22(90001): S79 - 93. [Abstract] [Full Text] [PDF]

				T. Rink, H.-J. Schroth, L.-H. Holle, and H. Garth Limited Sensitivity of Parathyroid Imaging with 99mTc-Sestamibi/123I Subtraction in an Endemic Goiter Area J. Nucl. Med., September 1, 2002; 43(9): 1175 - 1180. [Abstract] [Full Text] [PDF]

				M. B. Gotway, G. P. Reddy, W. R. Webb, E. T. Morita, O. H. Clark, and C. B. Higgins Comparison between MR Imaging and Radiology, March 1, 2001; 218(3): 783 - 790. [Abstract] [Full Text]